Title |
Anti-IgE Treatment for Disorders Other Than Asthma
|
---|---|
Published in |
Frontiers in Medicine, September 2017
|
DOI | 10.3389/fmed.2017.00152 |
Pubmed ID | |
Authors |
Jeffrey Stokes |
Abstract |
Immunoglobulin E (IgE) plays a key role in the pathogenesis of many allergic diseases. Thus, IgE-mediated immunologic pathways are an attractive target for intervention in allergic diseases. Omalizumab is a recombinant humanized monoclonal antibody that binds IgE and has been used treat allergic asthma for over a decade. Currently, omalizumab is approved for the treatment of both allergic asthma and chronic spontaneous urticaria. Since IgE plays a critical role in other allergic diseases, anti-IgE therapy has been evaluated in other allergic diseases in small clinical trials and case reports. Omalizumab has demonstrated efficacy in treating allergic rhinitis, atopic dermatitis, physical urticarias, mast cell disorders, food allergy, and other allergic diseases. In addition, the use of omalizumab with conventional allergen immunotherapy improves both safety and effectiveness. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Poland | 2 | 18% |
United Kingdom | 1 | 9% |
United States | 1 | 9% |
Australia | 1 | 9% |
Unknown | 6 | 55% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 7 | 64% |
Practitioners (doctors, other healthcare professionals) | 3 | 27% |
Scientists | 1 | 9% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 50 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 10 | 20% |
Student > Master | 7 | 14% |
Student > Postgraduate | 4 | 8% |
Student > Ph. D. Student | 3 | 6% |
Student > Doctoral Student | 2 | 4% |
Other | 7 | 14% |
Unknown | 17 | 34% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 13 | 26% |
Biochemistry, Genetics and Molecular Biology | 7 | 14% |
Agricultural and Biological Sciences | 4 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
Nursing and Health Professions | 1 | 2% |
Other | 5 | 10% |
Unknown | 19 | 38% |